130) isease that predominantly affects elderly patients. |
131) e areas) is consistently described in OCD patients. |
132) ols was significantly better than that of patients. |
133) etard the onset of foot ulcer in diabetic patients. |
134) measures geared toward the needs of these patients. |
135) mains a major health problem for diabetic patients. |
136) ssive in hypertensive management for male patients. |
137) cision of the tumour was performed in all patients. |
138) ntion that can be safely applied to these patients. |
139) for many medical conditions in veterinary patients. |
140) manage treatment-resistant schizophrenia patients. |
141) on is a common comorbidity among diabetic patients. |
142) M is useful to promote health in diabetic patients. |
143) nsible for an increased CDV risk in these patients. |
144) d valid for use with methadone-maintained patients. |
145) evision was achieved in 48 of 55 (87·3%) patients. |
146) problem, especially in immunocompromised patients. |
147) currence and tumour-related death between patients. |
148) excellent outcomes in carefully selected patients. |
149) dividuals that may be lacking in diabetic patients. |
150) hniques useful for the management of such patients. |
151) e performed with good results in very old patients. |
152) re administered to each of the 23 (18.4%) patients. |
153) improvements in some treatment-resistant patients. |
154) to occur in both canine and human cancer patients. |
155) elational representations of narcissistic patients. |
156) ctive to the treatment of PBF in selected patients. |
157) e critical issues in medical and surgical patients. |
158) TEHVs, providing more rapid treatment for patients. |
159) was detected in 78.57% of ovarian cancer patients. |
160) ry procedure was performed in 114 (20.8%) patients. |
161) the major cause of death in severe burns patients. |
162) tion avoidance was explained to all three patients. |
|